{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:40:44Z","timestamp":1767926444794,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bpg.2010.09.001","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T17:40:39Z","timestamp":1298050839000},"page":"619-628","source":"Crossref","is-referenced-by-count":41,"title":["Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly"],"prefix":"10.1016","volume":"24","author":[{"given":"Stephan","family":"vom Dahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.09.001_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.09.001_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF02436762","article-title":"Elevated plasma chitotriosidase activity in various lysosomal storage disorders","volume":"18","author":"Guo","year":"1995","journal-title":"Inherit Metab Dis"},{"key":"10.1016\/j.bpg.2010.09.001_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0168-8278(99)80356-0","article-title":"Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation","volume":"31","author":"vom Dahl","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.09.001_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-006-0363-3","article-title":"Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A\/B and C","volume":"29","author":"Ries","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bpg.2010.09.001_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bpg.2010.09.001_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.09.001_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpg.2010.09.001_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s002610000010","article-title":"Gaucher disease of the spleen: CT and MR findings","volume":"25","author":"Poll","year":"2000","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.bpg.2010.09.001_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08035320510028102","article-title":"Clinical evaluation of biomarkers in Gaucher disease","volume":"94","author":"Deegan","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.bpg.2010.09.001_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1185\/030079906X104623","article-title":"Evidence-based recommendations for the treatment and monitoring of bone disease in Gaucher patients","volume":"22","author":"vom Dahl","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpg.2010.09.001_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bpg.2010.09.001_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.11193","article-title":"Therapy of adult Gaucher disease","volume":"92","author":"Schmitz","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bpg.2010.09.001_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2010.09.001_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GIM.0b013e31818e2c19","article-title":"Dose-response relationships for enzyme replacement therapy with imiglucerase\/alglucerase in patients with Gaucher disease type 1","volume":"11","author":"Grabowski","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.bpg.2010.09.001_bib15","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1517\/14656560903270520","article-title":"Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose \u2013 response relationships","volume":"10","author":"Hollak","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bpg.2010.09.001_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of Enzyme Replacement Therapy With Imiglucerase on BMD in Type 1 Gaucher Disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bpg.2010.09.001_bib17","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-02-268649","article-title":"Phase I\/II and extension study of velaglucerase alfa (Gene-ActivatedTM human glucocerebrosidase) replacement therapy in adults with type 1 Gaucher disease: 48-month experience","author":"Zimran","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2010.09.001_bib18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.09.001_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bpg.2010.09.001_bib20","first-page":"703","article-title":"Short-term effect of miglustat in every day clinical use in treatment-naive or previously treated patients with type 1 Gaucher's disease","volume":"91","author":"Giraldo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bpg.2010.09.001_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bpg.2010.09.001_bib22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bcp.2006.12.015","article-title":"Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase","volume":"73","author":"Steet","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bpg.2010.09.001_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1172\/JCI106997","article-title":"Enzyme deficiency in cholesteryl ester storage disease","volume":"51","author":"Sloan","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2010.09.001_bib24","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/S0021-9258(19)40786-2","article-title":"Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease","volume":"250","author":"Goldstein","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.09.001_bib25","first-page":"1190","article-title":"Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency","volume":"36","author":"Hoeg","year":"1984","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpg.2010.09.001_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-2275(20)39900-4","article-title":"A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease","volume":"36","author":"Ameis","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bpg.2010.09.001_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2009.02.007","article-title":"Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene","volume":"97","author":"Pisciotta","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bpg.2010.09.001_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/104303402760128586","article-title":"Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice","volume":"13","author":"Du","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bpg.2010.09.001_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-0004.1984.tb04367.x","article-title":"Cholesterol ester storage disease in an adult presenting with sea-blue histiocytosis","volume":"26","author":"Besley","year":"1984","journal-title":"Clin Genet"},{"key":"10.1016\/j.bpg.2010.09.001_bib30","first-page":"133","article-title":"Niemann-Pick diseases","volume":"vol. 66","author":"Vanier","year":"1996"},{"key":"10.1016\/j.bpg.2010.09.001_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpeds.2006.06.034","article-title":"Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease","volume":"149","author":"Wasserstein","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.bpg.2010.09.001_bib32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/345074","article-title":"The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype\/phenotype correlations","volume":"71","author":"Simonaro","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpg.2010.09.001_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2003.07.008","article-title":"Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of Niemann-Pick disease","volume":"8","author":"Jin","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.bpg.2010.09.001_bib34","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"Faseb J"},{"key":"10.1016\/j.bpg.2010.09.001_bib35","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/sj.gt.3301300","article-title":"Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease","volume":"7","author":"Miranda","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.bpg.2010.09.001_bib36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbamcr.2008.11.015","article-title":"Molecular basis of multiple sulfatase deficiency, mucolipidosis II\/III and Niemann-Pick C1 disease \u2013 Lysosomal storage disorders caused by defects of non-lysosomal proteins","volume":"1793","author":"Dierks","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bpg.2010.09.001_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bpg.2010.09.001_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.09.001_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Hum Genomics"},{"key":"10.1016\/j.bpg.2010.09.001_bib40","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3733","article-title":"Fabry's disease?","author":"Desnick","year":"2001"},{"key":"10.1016\/j.bpg.2010.09.001_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpg.2010.09.001_bib42","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bpg.2010.09.001_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2010.09.001_bib44","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-03-273151","article-title":"A Phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1","author":"Lukina","year":"2010","journal-title":"Blood"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T04:21:34Z","timestamp":1637295694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1521691810001101"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.09.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}